Plasma polymerized nanoparticles effectively deliver dual siRNA and drug therapy in vivo

Multifunctional nanocarriers (MNCs) promise to improve therapeutic outcomes by combining multiple classes of molecules into a single nanostructure, enhancing active targeting of therapeutic agents and facilitating new combination therapies. However, nanocarrier platforms currently approved for clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Michael, Praveesuda, Lam, Yuen Ting, Filipe, Elysse C., Tan, Richard P., Chan, Alex H. P., Lee, Bob S. L., Feng, Nicolas, Hung, Juichien, Cox, Thomas R., Santos, Miguel, Wise, Steven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393381/
https://www.ncbi.nlm.nih.gov/pubmed/32732927
http://dx.doi.org/10.1038/s41598-020-69591-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393381/
https://www.ncbi.nlm.nih.gov/pubmed/32732927
http://dx.doi.org/10.1038/s41598-020-69591-x

Ejemplares similares